Interactions of anthracyclines with zwitterionic phospholipid monolayers at the air-water interface.
The present note describes the use of surface pressure measurements (Langmuir monolayer technique) for the analysis of interactions of two different anthracyclines (adriamycin and daunorubicin) with a non-ionic, zwitterionic phospholipid monolayer, at the air-water interface. Because the surface membrane of the cell is the first barrier encountered by the anthracyclines in the treatment of cancer, drug-membrane interactions studied in model (monolayers or bilayers) and natural systems play an important role in the understanding of the bioactivity properties of these molecules. We report here the rate constants of the adsorption process of adriamycin and daunorubicin in the presence of a zwitterionic phospholipid monolayer at the air-water interface. Because interactions with the lipid monolayer strongly depend on the molecular packing of the lipid, we investigated this process at a relatively low surface pressure (7 mN/m), the interactions being favoured by the gaseous and liquid expanded structure of the lipid monolayer. The apparent molecular area of these molecules during the insertion into the lipid film and their interactions with the phospholipid polar head groups was evaluated and the estimated percentage of anthracyclines at the interface after adsorption into the lipid monolayer is briefly discussed. The rate constants for the adsorption and desorption process at the water-monolayer interface have been calculated on the basis of a single-exponential model. The observed difference of these parameters for daunorubicin and adriamycin suggests a different interaction of these anthracyclines during the adsorption to and/or penetration across the phospholipid monolayer.
Bordi
F
F
Dipartimento di Medicina Interna, Universita' di Roma Tor Vergata, Rome, Italy.
Cametti
C
C
Motta
A
A
Diociaiuti
M
M
Molinari
A
A
D000388:Air; D000903:Antibiotics, Antineoplastic / Q000737:chemistry*; D003630:Daunorubicin / Q000737:chemistry*; D004317:Doxorubicin / Q000737:chemistry*; D010714:Phosphatidylethanolamines / Q000737:chemistry*; D014867:Water
D000903:Antibiotics, Antineoplastic; D010714:Phosphatidylethanolamines; D014867:Water; D004317:Doxorubicin; C018525:1,2-dimyristoylphosphatidylethanolamine; D003630:Daunorubicin